Lucy Robertshaw is very excited to be moderating the event The Future of Swedish and Danish Life Science being held at Medicon Village in Lund on 22nd March 2018.
Scandinavia has seen continued investment in the life sciences, and there are many examples of how this cash injection is translating into real projects:
In the Lund-based life science research park, Medicon Village, construction of a new purpose-built complex that will house 600 experts, is in full swing.
In the past 10 years personalized medicine, now precision medicine, has been a highly attractive concept to many stakeholders in the industry. The Danish Government and Danish Regions have developed a National Strategy for Personalized Medicine 2017-2020. This is hardly surprising. Giving the patients the information and ability to find out exactly which drugs work for them, is just one of the supposed advantages. But looking past the hype, when will the promised benefits of these procedures become reality? And how will the payment systems, the industry and the health sector, as well as the individual doctor, follow this trend?
In addition to this, the industry must address the looming challenge of “Big Data”. Every day, biobanks, as well as new progress in genetics and molecular biology, create huge amounts of raw data. But do we have the tools needed to make use of it, and in the longer perspective, turn it into an additional revenue stream? We also want to investigate how the Nordic countries can improve their collaboration in these areas, both at home and across borders.
We are looking for speakers for the programme so do let us know if you would like to be part of this event.
This will be the 5th year of attending the One Nucleus Genesis Conference in Westminster, London being held on 14th December and this year Lucy Robertshaw will be chairing the panel debate “Genomics to Economics: Right Treatment, Right Patient, Right Time”.
The increasing capacity in fields such as proteomics, metabolomics and glycomics is enhancing our ability to understand the molecular basis of pathophysiologies at rates never before observed.
Fundamental to progress however are the two bookend ‘omics – genomics and economics. This session will discuss how advances in areas such as gene editing and patient stratification are enabling R&D that will deliver well targeted and affordable health outcomes.
Lucy Robertshaw commented that she is very interested to learn where we are in the development of gene editing and how much more work we need to do to get to where we need to be.
On Wednesday 11th October at Operaterrassen in Stockholm saw the gathering of 50 top influencers in the Life Science Sector for a VIP gala dinner.
Our guest of honour for the evening was Jan-Olof Jacke who is the president of AstraZeneca AB thought it was a great idea to celebrate the life science sector as we don’t do this enough, he also said that big data is going to be a challange with the digitalisation world that the life science sector is currently going through.
He and AstraZeneca are really championing openess but this also needs infrastructure which is already set up in the form of the Astrazeneca bioventurehub in Molndal, Sweden, the people who are there have the exact same access as the employed people of AstraZeneca.
We also heard from Kerstin Jacobsson about the exciting new office complex which is being currently being built at Medicon Village and will house 600 additional people this will open in December 2018.
We would like to thank everyone for making this such a great event.
On 11th October the life science sector will join together in Stockholm for the evening for the Life Science Gala Dinner, we have 50 attendees confirmed for dinner.
Our Key-note speaker is Jan-Olof Jacke from AstraZeneca and very much looking forward to listening to his thoughts about the future for AstraZeneca in Sweden.
We have 5 partners who are hosting tables:
Having attended the past 3 years of the NLS days in Stockholm, this year the event is being held in the heart of Medicon Valley and will be atteneded by a number of other countries as well.
I will be representing Pharma Publications in my role as editor of the International Pharmacetical Industry magazine, I have already started to request partnering meetings which I feel is really a important part of the event so its never to early to start.
I look forward to seeing everyone there!
Lucy Robertshaw will be the chair for the afternoon session of the Biotech Investment Programme at the Anglo Nordic Life Science Confernece in London on Wednesday 31st May.
She will also be presenting the Nordic Overview for Life Sciences where it will be presented the events which should not be missed in 2017 being held in Sweden.
LucyJRobertshaw have been the proud co-organisers of the event and have been in attendance for the past 3 years.
I once again for the 3rd year moderated the Future of Swedish and Danish Life Science at Medicon Village which is in the heart of Medicon Valley and we had a a great time.
New connections were made yesterday when a wide range of people were brought together at the sixth annual international networking forum, The Future of Swedish and Danish life science. Medicon Village joined forces with Kemivärlden Biotech/Journal of Chemistry and Biotechnology and Medicon Valley Alliance to organize the forum.
And they targeted decision makers in the pharma, biotech, medtech and health care sectors, persons from research and development in both industry and academia, along with investors, authorities and politicians. A wide range of participants pointed out the great value in meeting face to face.
– I´m here to be inspired by how I can bridge my public health degree with the pharma industry. This event is bringing many actors together in one spot, where we are able to meet face to face, says Keeva Duffey, mph-student at Lund University.
Some 35 exhibitors and nearly 520 participants engaged in conversations. And they had ample opportunities to make new connections or to touch base on a more informal basis during the frequent coffee breaks.
– We think it´s very interesting and fun to take part and see what´s happening in the world of life science, in particular in this region. Our niche lies within the life sciences, and here we have a big opportunity to meet both clients and potential candidates, Eva Runnerström, recruitment consultant at PeakSearch, points out.
Also a delegate of ten collaboration partners from the U.K keeps Sweden and Denmark on the radar.
– The purpose of coming here is about connections. It´s connections not only in terms of raising our profile here and seeking new clients, but it´s actually new expertise, says Greer Deal, director at GRS® and continues. Who have you got locally, who we can work with, who we can collaborate with? We can bring all that expertise together to provide a holistic solution to our clients in the global life science sector.
Copied from http://www.mediconvillage.se/sv/node/449
I attended this years Stockholm Corporate Finance Life Science Seminar which is run every year and this is my 3rd year of attending.
More than 400 people participated in the Stockholm Corporate Finance Ninth Life Science seminar held on 21 and 22 March in cooperation with us at Financial Hearings and the news agency Direct. There were 16 companies that presented. These corresponding to a total market value of approximately SEK 15 billion. Investor Interest in Life Science sector continues to increase among both institutions, asset managers and private equity investors.
SCFs CEO Peter Enstrom began by informing about the present, 16 companies are an important part of the Swedish Life Science industry. Many companies are relatively small and are working under difficult financial circumstances, but their research, which in recent years has become increasingly sophisticated, will change many people’s health and lives. “Research with the support of venture capital is a necessity today to get a broad and vigorous Swedish Life Science industry to compete in the international market with the goal of becoming a world leader.”
Addlife, Bactiguard, Camurus, Dignitana US Inc, Hansa Medical, index Pharma, IRLAB, Karolinska Development, MedCap, Medivir Pharma Moberg, Oasmia Pharmaceutical, Orexo, Redwood Pharma SciBase, and Wnt Reserarch.
Yesterday evening I attended for the 3rd year a event that is run by The Swedish Chamber of Commerce in London a event that was called (Are you still) welcome to the UK? of course talking about the Brexit situation.
This started off by The British Ambassador to Sweden David Cairns who said that the UK had a great opportunity to create closer relationships with the rest of the world following the announcement of Brexit plus that he hopes that business will not be affected by this plus the country is very welcoming and gave a “varmt välkommen” to everyone in Swedish.
This was then closely followed on by James Savage, Co-founder of The Local which is a written online newspaper for English written news and he went onto say that Brexit has caused huge issues with the question over immigration, here is Sweden the application for Swedish citizenship tripled after the announcement. He also mentioned the price for difference in applications in different member states will also make it harder for people to stay in the countries they currently reside.
Stefan Backlund a year ago decided to set up a office in London due to this being the number financial place in the world, to set up Trustly that is a fin tech online banking payment solution which they have has a really positive time by now employing 6 people and looking to take another 20/25 people.
Everyone since the announcement seems to have also become experts at trying to make sense of what the future 2 years will look like with the separation from the UK, Garvan Walsh from Brexit Analytics commented that he feels that the UK market is now an emerging market which in one way of another probably is the case.
What I am personally astounded by is that the previous Prime Minister lead us to a referendum and there was no clear plan in place that should the yes we want the UK to leave the European Union there would not be a time as such that everyone is left in the dark or not so, social media today comments on every possible angle of the good, bad plus ugly information that is said.
I think that this has left the brand of the UK in complete confusion on where the question on everyone minds in business, is this a country that we want to do business with or set up a business on the soil of the UK. I also really wonder what people would be talking about had this not actually happened?